Evaluation of potential causes for the incomplete bioavailability of furosemide: Gastric first-pass metabolism
Tóm tắt
Từ khóa
Tài liệu tham khảo
M. R. Kelly, R. E. Cutler, A. W. Forrey, and B. M. Kimpel. Pharmacokinetics of orally administered furosemide.Clin. Pharmacol. Ther. 15:178–186 (1974).
E. S. Waller, S. F. Hamilton, J. W. Massarella, M. A. Sharanevych, R. V. Smith, G. J. Yakatan, and J. T. Doluisio. Disposition and absolute bioavailability of furosemide in healthy males.J. Pharm. Sci. 71:1105–1108 (1982).
R. A. Branch, C. J. C. Roberts, M. Homeida, and D. Levine. Determinants of response to furosemide in normal subjects.Br. J. Clin. Pharmacol. 4:121–127 (1977).
A. Rane, J. P. Villeneuve, W. J. Seone, A. S. Nies, G. R. Wilkinson, and R. A. Branch. Plasma binding and disposition of furosemide in the nephrotic syndrome and uremia.Clin. Pharmacol. Ther. 24:199–207 (1978).
B. Beermann, E. Dalén, B. Lindstrom, and A. Rosén. On the fate of furosemide in man.Eur. J. Clin. Pharmacol. 9:57–61 (1975).
D. E. Smith, E. C. Lin, and L. Z. Benet. Absorption and disposition of furosemide in healthy volunteers, measured with a metabolic-specific assay.Drug Metab. Dispos. 8:337–342 (1981).
D. C. Brater, R. Seiwell, S. Andreasen, A. Burdette, G. J. Dekmer, and P. Chennavasin. Absorption and disposition of furosemide in congestive heart failure.Kidney Int. 22:171–176 (1982).
C. M., Huang, A. J. Atkinson, Jr., M. Levin, and A. Quintanilla. Pharmacokinetics of furosemide in advanced renal failure.Clin. Pharmacol. Ther. 16:659–666 (1974).
A. Greither, S. Goldman, J. S. Edelen, L. Z. Benet, and K. Cohn. Absorption of furosemide in patients with congestive heart failure.Pharmacology 19:121–131 (1979).
M. R. Kelly, A. D. Blair, A. W. Forrey, N. A. Smidt, and R. A. Cutler. A comparison of the diuretic response to oral and intravenous furosemide in “diuretic-resistant‘ patients.Curr. Ther. Res. 21:1–9 (1977).
G. J. Yakatan, D. D. Maness, J. Scholler, J. T. Johnson, W. J. Novick, Jr., and J. T. Doluisio. Plasma and tissue levels of furosemide in dogs and monkeys following single and multiple oral doses.Res. Commun. Chem. Pathol. Pharmacol. 24:465–482 (1979).
G. J. Yakatan, D. D. Maness, J. Scholler, W. J. Novick, Jr., and J. T. Doluisio. Absorption, distribution, metabolism, and excretion of furosemide in dogs and monkeys I. Analytical methodology, metabolism, and urinary excretion.J. Pharm. Sci. 65:1456–1460 (1976).
L. Z. Benet. Pharmacokinetics/pharmacodynamics of furosemide in man: a review.J. Pharmacokin. Biopharm. 7:1–27 (1979).
R. E. Cutler and A. D. Blair. Clinical pharmacokinetics of furosemide,Clin. Pharmacokin. 4:279–296 (1979).
V. S. Chungi, L. W. Dittert, and R. B. Smith. Gastrointestinal sites of furosemide absorption in rats.Int. J. Pharm. 4:27–38 (1979).
J. E. Cruz, D. D. Maness, and J. G. Yakatan. Kinetics and mechanism of hydrolysis of furosemide.Int. J. Pharm. 2:275–281 (1979).
F. Andreasen, H. E. Boetker, and K. Lorentzen.In vitro studies in the hydrolysis of furosemide in gastrointestinal juices.Br. J. Clin. Pharmacol 14:306–309 (1982).
Remington's Pharmaceutical Sciences, 15th ed. Mack Publishing Co., Easton, Pa., 1975, p. 872.
J. Honari, A. D. Blair, and R. E. Cutler. Effect of probenecid on furosemide kinetics and natriuresis in man.Clin. Pharmacol. Ther. 22:395–401 (1977).
F. Andreasen, O. L. Pedersen, and E. Mikkelsen. Distribution, elimination, and natriuretic effect of furosemide in patients with severe arterial hypertension.Eur. J. Clin. Pharmacol. 14:237–244 (1978).
M. G. Lee, M. L. Chen, and W. L. Chiou. Pharmacokinetics of drugs in blood II: Unusual distribution and storage effect of furosemide.Res. Commun. Chem. Pathol. Pharmacol. 34:17–28 (1981).
M. L. Chen, M. G. Lee, and W. L. Chiou. Pharmacokinetics of drugs in blood III: Metabolism of procainamide and storage effect of blood samples.J. Pharm. Sci. 72:572–574 (1983).
C. L. Litterst, E. G. Mimnaugh, R. I. Reagan, and T. E. Gram. Comparison ofin vitro drug metabolism by lung, liver and kidney of several common laboratory species.Drug Metab. Dispos. 3:259–265 (1975).
R. L. Nation, G. W. Peng, and W. L. Chiou. Quantitative analaysis of furosemide in microplasma volumes by high performance liquid column chromatography.J. Chromatogr. Biomed. Appl. 162:88–93 (1979).
M. G. Lee. Absorption and disposition of furosemide. Ph.D. thesis, University of Illinois, Chicago, 1982.
M. L. Chen, G. Lam, M. G. Lee, and W. L. Chiou. Arterial and venous blood sampling in pharmacokinetic studies: Griseofulvin.J. Pharm. Sci. 71:1386–1389 (1982).
W. L. Chiou. Critical evaluation of potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curve.J. Pharmacokin. Biopharm. 6:539–546 (1978).
H. J. Baker, J. R. Lindsey, and S. H. Weisbroth.The Laboratory Rat. Vol. I. Biology and Diseases. Academic Press, New York, 1979, p. 87.
W. L. Chiou, C. Y. Lui, and G. Lam. Limitation of the plasma area method in the relative bioavailability evaluation of drugs with changing biological half-lives.J. Pharm. Sci. 70:109–112 (1981).
K. C. Kwan and A. E. Till. Novel method for bioavailability assessment.J. Pharm. Sci. 7:527–536 (1979).
S. Øie and D. Jung. Bioavailability under variable renal clearance conditions.J. Pharm. Sci. 68:128–129 (1979).
W. L. Chiou. New calculation method for mean apparent drug volume of distribution and application to rational dosage regimens.J. Pharm. Sci. 68:1067–1069 (1979).
R. Fuller, C. Hoppel, and S. T. Ingalls. Furosemide kinetics in patients with hepatic cirrhosis with ascites.Clin. Pharmacol. Ther. 30:461–467 (1981).
R. K. Verbeeck, J. F. Gerkens, G. P. Wilkinson, and R. A. Branch. Disposition of furosemide in functionally hepatectomized dogs.J. Pharmacol. Exp. Ther.,216:479–483 (1981).
M. M. Hammarlund and L. K. Paalzow. Dose-dependent pharmacokinetics of furosemide in the rat.Biopharm. Drug Dispos. 3:345–359 (1982).
D. E. Smith and L. Z. Benet. Relationship between urinary excretion rate, steady-state plasma levels and diuretic response of furosemide in the rat.Pharmacology 19:301–306 (1979).
T. P. Green and B. L. Mirkin. Furosemide disposition in normal and proteinuric rats: urinary drug-protein binding as a determinant of drug excretion.J. Pharmacol. Exp. Ther. 218:122–127 (1981).
S. Inui, M. Yamamoto, H. Nakae, and S. Asada. Dose dependency of loop diuretics, furosemide and piretanide in the rat.Yakugaku Zasshi. 102:1053–1060 (1982).
C. Lambert, G. Caille, and P. Du Souich. Nonrenal clearance of furosemide as a course of diuretic response variability in the rat.J. Pharmacol. Exp. Ther. 222:232–236 (1982).
J. D. Wallin, P. Ryals, and N. Kaplowicz. Metabolic clearance of furosemide in the rat.J. Pharmacol. Exp. Ther. 200:52–57 (1977).
P. C. Rowbotham, J. B. Stanford, and J. K. Sugden. Some aspects of the photochemical degradation of furosemide.Pharm. Acta Helv. 51:304–307 (1976).
S. M. Huang, Y. C. Huang, and W. L. Chiou. Oral absorption and presystemic first pass effect of chlorpheniramine in rabbits.J. Pharmacokin. Biopharm. 9:725–738 (1981).